Seastar Medical Holding Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US81256L1044
USD
2.48
1.21 (95.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

52.69 k

Shareholding (Sep 2025)

FII

0.23%

Held by 9 FIIs

DII

97.76%

Held by 2 DIIs

Promoter

0.00%

How big is Seastar Medical Holding Corp.?

22-Jun-2025

As of Jun 18, Seastar Medical Holding Corp. has a market capitalization of 10.05 million, with net sales of 0.43 million and a net profit of -15.91 million over the last four quarters. The balance sheet shows shareholder's funds of -2.18 million and total assets of 4.66 million.

As of Jun 18, Seastar Medical Holding Corp. has a market capitalization of 10.05 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company's net sales for the latest four quarters totaled 0.43 million, while the net profit for the same period was reported at -15.91 million.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of -2.18 million and total assets amounting to 4.66 million.

View full answer

What does Seastar Medical Holding Corp. do?

22-Jun-2025

Seastar Medical Holding Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $4 million as of March 2025. It has a market cap of $10.05 million and key metrics indicating significant financial challenges.

Overview: <BR>Seastar Medical Holding Corp. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -4 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 10.05 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -4.93 <BR>Return on Equity: -1,768.20% <BR>Price to Book: 10.05<BR><BR>Contact Details: <BR>Registrar Address: Not available.

View full answer

Is Seastar Medical Holding Corp. technically bullish or bearish?

20-Sep-2025

As of June 27, 2025, Seastar Medical Holding Corp. is in a mildly bearish trend, with daily moving averages indicating this stance, while it has underperformed significantly with a year-to-date return of -53.61% compared to the S&P 500's 12.22%.

As of 27 June 2025, the technical trend for Seastar Medical Holding Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a mildly bearish trend, while weekly and monthly MACD and RSI readings are mildly bullish and bullish, respectively. However, the Bollinger Bands show a bearish monthly trend, and Dow Theory indicates a mildly bearish stance on both weekly and monthly time frames. <BR><BR>In terms of performance, the stock has returned -53.61% year-to-date compared to the S&P 500's 12.22%, and it has significantly underperformed over the past year with a return of -81.71% versus the S&P 500's 17.14%.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 8 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.20

stock-summary
Return on Equity

-120.14%

stock-summary
Price to Book

0.71

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2025)
Net Profit:
-3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
30.53%
0%
30.53%
6 Months
10.22%
0%
10.22%
1 Year
-41.09%
0%
-41.09%
2 Years
-83.03%
0%
-83.03%
3 Years
-99.02%
0%
-99.02%
4 Years
-99.0%
0%
-99.0%
5 Years
0%
0%
0.0%

Seastar Medical Holding Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
20.96%
EBIT Growth (5y)
-307.72%
EBIT to Interest (avg)
-8.99
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-4.93
Sales to Capital Employed (avg)
0.03
Tax Ratio
0.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.46%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
13.15
EV to EBIT
-0.46
EV to EBITDA
-0.46
EV to Capital Employed
-1.88
EV to Sales
8.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-1768.20%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (2.0%)

Foreign Institutions

Held by 9 Foreign Institutions (0.23%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 100.00% vs 0.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 22.22% vs 37.50% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.20",
          "val2": "0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.60",
          "val2": "-4.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.30",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.50",
          "val2": "-4.50",
          "chgp": "22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-19,557.40%",
          "val2": "-65,529.40%",
          "chgp": "4,597.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.34% vs -114.75% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.80",
          "val2": "-14.20",
          "chgp": "-25.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "1.10",
          "chgp": "-81.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.80",
          "val2": "-9.80",
          "chgp": "30.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-24.80",
          "val2": "-26.20",
          "chgp": "5.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-132,163.00%",
          "val2": "0.00%",
          "chgp": "-13,216.30%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
0.20
0.10
100.00%
Operating Profit (PBDIT) excl Other Income
-3.60
-4.50
20.00%
Interest
0.00
0.30
-100.00%
Exceptional Items
0.00
0.20
-100.00%
Consolidate Net Profit
-3.50
-4.50
22.22%
Operating Profit Margin (Excl OI)
-19,557.40%
-65,529.40%
4,597.20%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 100.00% vs 0.00% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 22.22% vs 37.50% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
0.10
0.00
Operating Profit (PBDIT) excl Other Income
-17.80
-14.20
-25.35%
Interest
0.20
1.10
-81.82%
Exceptional Items
-6.80
-9.80
30.61%
Consolidate Net Profit
-24.80
-26.20
5.34%
Operating Profit Margin (Excl OI)
-132,163.00%
0.00%
-13,216.30%
USD in Million.
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 5.34% vs -114.75% in Dec 2023

stock-summaryCompany CV
About Seastar Medical Holding Corp. stock-summary
stock-summary
Seastar Medical Holding Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available